The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

M.D. Dibirov

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

R.U. Gadzhimuradov

Department of Surgical Diseases and Clinical Angiology, Moscow State University of Medicine and Dentistry;
City Clinical Hospital №81, Moscow

K.A. Koreĭba

Kafedra obshcheĭ khirurgii Kazanskogo gosudarstvennogo meditsinskogo universiteta, Tsentr "Diabeticheskaia stopa", Kazan'

Analysis of the clinical application of epidermal growth factor ("Heberprot-P") and bioplastic material ("Collost") in treatment of skin and soft tissues defects in patients with diabetic foot syndrome

Authors:

M.D. Dibirov, R.U. Gadzhimuradov, K.A. Koreĭba

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2016;(3): 59‑63

Views: 851

Downloaded: 20

To cite this article:

Dibirov MD, Gadzhimuradov RU, Koreĭba KA. Analysis of the clinical application of epidermal growth factor ("Heberprot-P") and bioplastic material ("Collost") in treatment of skin and soft tissues defects in patients with diabetic foot syndrome. Pirogov Russian Journal of Surgery. 2016;(3):59‑63. (In Russ.)
https://doi.org/10.17116/hirurgia2016359-63

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.